Purple Biotech Ltd. (PPBT) Financials
PPBT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 14.2 million | 2.0 million |
| March 31, 2026 | 14.4 million | 4.8 million |
| Dec. 31, 2025 | 17.6 million | 7.9 million |
| Sept. 30, 2025 | 39.1 million | 6.2 million |
PPBT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.5 million | 67000 |
| March 31, 2026 | -3.1 million | 93000 |
| Dec. 31, 2025 | -1.1 million | -43000 |
| Sept. 30, 2025 | -1.1 million | 200000 |
PPBT Net Income
No data available :(
PPBT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | - | - | 134000 |
| March 31, 2026 | 6.4 million | - | 184000 |
| Dec. 31, 2025 | 9.6 million | - | 244000 |
| Sept. 30, 2025 | 10.5 million | - | 256000 |
PPBT Shares Outstanding
PPBT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 702000 | 597000 | - |
| March 31, 2026 | - | 1.2 million | 1.0 million | - |
| Dec. 31, 2025 | 1.0 million | 1.8 million | 1.1 million | - |
| Sept. 30, 2025 | 1.0 million | 587000 | 780000 | - |
PPBT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 64823 |
| Dec. 31, 2025 | - | 53331 |
| Sept. 30, 2025 | - | 58272 |
PPBT
Price: $1.08
52 week price:
Earnings Per Share: -53.20 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 20300
Market Capitalization: 208507